SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 11, 2003
CompuMed, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
0-14210 |
|
95-2860434 |
||
|
(State or other jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
||
|
|
|
|
|
|
||
|
5777 W. Century Blvd, Suite 1285, |
|
90045 |
||||
|
(Address of principal executive offices) |
|
(Zip Code) |
||||
|
|
|
|
||||
|
Registrant’s telephone number, including area code: (310) 258-5000 |
||||||
Item 9. Regulation FD Disclosure
The following information is furnished pursuant to Item 9, “Regulation FD Disclosure” and Item 12, “Results of Operations and Financial Condition.”
On August 11, 2003, CompuMed, Inc. (“CompuMed”) issued a press release setting forth CompuMed’s third-quarter 2003 earnings. A copy of CompuMed’s press release is attached hereto as Exhibit (99) and hereby incorporated by reference.
Item 12. Results of Operation and Financial Condition
The following information is furnished pursuant to Item 9, “Regulation FD Disclosure” and Item 12, “Results of Operations and Financial Condition.”
On August 11, 2003, CompuMed, Inc. (“CompuMed”) issued a press release setting forth CompuMed’s third-quarter 2003 earnings. A copy of CompuMed’s press release is attached hereto as Exhibit (99) and hereby incorporated by reference.
2
Exhibit Index
(99)
Press release, dated: August 11, 2003, issued by CompuMed, Inc.
3
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
CompuMed, Inc. |
||
|
|
|
||
|
|
By: |
/s/ JOHN G. MCLAUGHLIN |
|
|
|
|
John G. McLaughlin |
|
|
|
|
President and Chief Executive Officer |
|
|
|
|
|
|
|
Date: August 11, 2003 |
|
|
|
4